Lung Cancer News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Lacking Details, Roche Touts Drug Combo's Success in Lung Cancer - Xconomy



Xconomy
 
Lacking Details, Roche Touts Drug Combo's Success in Lung Cancer 
Xconomy
Roche's Genentech division reported this morning that its cancer immunotherapy drug, atezolizumab (Tecentriq), has succeeded in a clinical study that could help change the standard of care for people with a certain type of lung cancer. The South San ...
Roche says Tecentriq combination cuts lung cancer risk Reuters
Roche reshuffles lung cancer immunotherapy market with positive clinical trial results STAT
Roche lung cancer results boost Tecentriq versus I/O rivals BioPharma Dive
Seeking Alpha  -Forbes 
all 30 news articles » 


Scan building lung cancer awareness - Elizabethtown News Enterprise



Elizabethtown News Enterprise
 
Scan building lung cancer awareness 
Elizabethtown News Enterprise
McCandless decided to undergo the procedure, which offers a lower dose of radiation, at the urging of Dr. Navin Kaini, who treats critical care patients in the hospital and those with chronic lung conditions at Hardin Memorial Health Pulmonary and ...

 


10 Frightening Lung-Cancer Statistics and 3 Top Companies ... - Motley Fool



10 Frightening Lung-Cancer Statistics and 3 Top Companies ... 
Motley Fool
At the other end of the spectrum is the deadliest cancer of them all in terms of sheer numbers: lung cancer. Below are 10 frightening statistics that describe why ...

and more » 


Osimertinib improves progression-free survival in Asian EGFR-mutated lung cancer patients - Medical Xpress



Hindu Business Line
 
Osimertinib improves progression-free survival in Asian EGFR-mutated lung cancer patients 
Medical Xpress
Osimertinib improves progression-free survival compared to standard first line therapy in Asian patients with EGFR-mutated non-small-cell lung cancer (NSCLC), according to the Asian subset analysis of the FLAURA trial presented at the ESMO Asia 2017 ...
Osimertinib superior to standard first-line treatments for EGFR-mutated lung cancer Healio
BRIEF?Tagrisso data show benefits in fighting lung cancer complication The Pharma Letter
AstraZeneca touts Tagrisso's CNS benefit BioPharma Dive
Hindu Business Line 
all 5 news articles » 


'I Was Diagnosed With Lung Cancer At 19, And I'm Still Fighting It 5 Years Later' - Women's Health



Women's Health
 
'I Was Diagnosed With Lung Cancer At 19, And I'm Still Fighting It 5 Years Later' 
Women's Health
And years later, when the cancer spread to my brain and to my spine, it was still hard to fathom that a 19-year-old, healthy, active, non-smoking college student could get stage II non-small cell lung cancer in the first place. I've since learned that ...

 


Early detection can save some lung cancer patients -- not my Dad - Greenville News



Greenville News
 
Early detection can save some lung cancer patients -- not my Dad 
Greenville News
Then came the diagnosis that no one expected since he was not a smoker -- Stage 4 non-small cell lung cancer. And the cancer had spread.

and more » 


Myths about lung cancer - KFSN-TV



Myths about lung cancer 
KFSN-TV
The problem is lung cancer is often caught too late, which leads to another myth, that there are no symptoms. Doctors say there are signs to watch for: a cough that doesn't go away, chest pain, weight loss, coughing up blood, or infections like ...

 


Health Minute: Lung Cancer Awareness Month | OzarksFirst - OzarksFirst.com



OzarksFirst.com
 
Health Minute: Lung Cancer Awareness Month | OzarksFirst 
OzarksFirst.com
WASHINGTON - November is lung cancer awareness month.

and more » 


Lung Cancer May Grow Faster During Immunotherapy - Medscape



Medscape
 
Lung Cancer May Grow Faster During Immunotherapy 
Medscape
YOKOHAMA, Japan ? With all the excitement over the improved survival seen in some patients with cancer treated with immunotherapy, little attention has been paid to the other side of the coin: the fact that some patients get worse. This phenomenon ...

 


Deep dive into lung cancer genomics offers new lens and lease on life - Markets Insider



Deep dive into lung cancer genomics offers new lens and lease on life 
Markets Insider
His BC Cancer oncologist, Dr. Janessa Laskin, also enrolled him in the Personalized Onco-Genomics (POG) program. It identified an RNA defect, which may have played a role in how he developed lung cancer, and showed a high probability that his cancer ...

and more »